Diferencia entre revisiones de «Template:Brain abscess antibiotics»
Sin resumen de edición |
(Prepared the page for translation) |
||
| Línea 1: | Línea 1: | ||
<languages/> | |||
<translate> | |||
====Otogenic source==== | ====Otogenic source==== | ||
*[[Cefotaxime]] 2gm IV q6hr + [[metronidazole]] 500mg IV q6hr | |||
*[[Special:MyLanguage/Cefotaxime|Cefotaxime]] 2gm IV q6hr + [[Special:MyLanguage/metronidazole|metronidazole]] 500mg IV q6hr | |||
====Sinogenic or odontogenic source==== | ====Sinogenic or odontogenic source==== | ||
*[[Cefotaxime]] 2gm IV q6hr + [[metronidazole]] 500mg IV q6hr | |||
*[[Special:MyLanguage/Cefotaxime|Cefotaxime]] 2gm IV q6hr + [[Special:MyLanguage/metronidazole|metronidazole]] 500mg IV q6hr | |||
====Penetrating trauma or neurosurgical procedures==== | ====Penetrating trauma or neurosurgical procedures==== | ||
*[[Vancomycin]] 15mg/kg IV q12hr + [[ceftazidime]] 2gm IV q8hr | |||
*[[Special:MyLanguage/Vancomycin|Vancomycin]] 15mg/kg IV q12hr + [[Special:MyLanguage/ceftazidime|ceftazidime]] 2gm IV q8hr | |||
====Hematogenous source==== | ====Hematogenous source==== | ||
*[[Cefotaxime]] 2gm IV q6hr + [[metronidazole]] 500mg IV q6hr | |||
*[[Special:MyLanguage/Cefotaxime|Cefotaxime]] 2gm IV q6hr + [[Special:MyLanguage/metronidazole|metronidazole]] 500mg IV q6hr | |||
====No obvious source==== | ====No obvious source==== | ||
*[[Cefotaxime]] 2gm IV q6hr + [[metronidazole]] 500mg IV q6hr | |||
*[[Special:MyLanguage/Cefotaxime|Cefotaxime]] 2gm IV q6hr + [[Special:MyLanguage/metronidazole|metronidazole]] 500mg IV q6hr | |||
</translate> | |||
Revisión del 04:33 26 ene 2026
Otogenic source
- Cefotaxime 2gm IV q6hr + metronidazole 500mg IV q6hr
Sinogenic or odontogenic source
- Cefotaxime 2gm IV q6hr + metronidazole 500mg IV q6hr
Penetrating trauma or neurosurgical procedures
- Vancomycin 15mg/kg IV q12hr + ceftazidime 2gm IV q8hr
Hematogenous source
- Cefotaxime 2gm IV q6hr + metronidazole 500mg IV q6hr
No obvious source
- Cefotaxime 2gm IV q6hr + metronidazole 500mg IV q6hr